Dsh/Dvl Phosphorylation and Signaling Outcome
Dsh/Dvl Phosphorylation and Signaling Outcome
批准号:
7714941
负责人:
Marek Mlodzik
金额:
$25.43万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-15 至 2011-07-31
关键词:
AddressAnimal ModelAnimal TestingApoptosisBiochemicalBiological AssayCell Culture TechniquesCell PolarityCell physiologyCellsComplementDataDefectDevelopmentDiagnosticDiseaseDrosophila genusEmbryoEpitheliumEventExcisionEyeFZD2 geneFamilyFelis catusGenerationsGrowth FactorHandHomeostasisImmune SeraInvertebratesLinkMalignant NeoplasmsMammalian CellMass Spectrum AnalysisMediatingMedicalMembraneMolecularOutcomePathway interactionsPatternPhospho-Specific AntibodiesPhosphorylationPhosphotransferasesPhotoreceptorsPhysiologicalPolycystic Kidney DiseasesProtein Tyrosine KinaseProto-OncogenesRecruitment ActivityRegulationResearchRoleSamplingSignal PathwaySignal TransductionSiteSpecificityStagingSurveysTimeTissuesTransducersTumor Suppressor ProteinsTyrosine PhosphorylationVisual FieldsWingangiogenesisbasecellular developmentflyin vitro Assayin vivomutantnovelpublic health relevancereceptorresearch studyresponsetool
中文摘要
描述(由申请人提供):卷曲(Fz)受体通过几种效应途径作为Wnt生长因子的信号转导器,特别是Wnt/2-catenin (2-cat)和Fz/平面细胞极性(PCP)信号。Fz/PCP和Wnt-Fz/2-cat信号在细胞质因子disheveled (Dsh)下游发散。通常这两种途径在同一组织中起作用,信号特异性的严格调节对正常发育和细胞稳态至关重要。在不受调控的情况下,选择错误的fz通路通常会导致疾病(即PKD或癌症)。虽然这两种通路的分子框架已经建立,但对Wnt/Fz-Dsh信号特异性的调控知之甚少。本应用研究了Wnt-Fz/2-Cat和Fz/PCP信号的分子特异性。我们将在果蝇(两种途径都被发现的模式生物)和哺乳动物细胞培养中解决这个问题。具体的重点是磷酸化对Dsh的调节。Dsh是两种途径共享的细胞质因子,由Fz受体募集到细胞膜上。根据初步数据,我们假设Dsh以一种途径特异性的方式被差异磷酸化。结合细胞培养、体内和生化研究将剖析Dsh上的磷酸化事件,这些磷酸化事件在Wnt- Fz通路之间切换其功能。具体目标是:1。确定Dsh的特定磷酸化事件及其在信号转导结果选择中的作用;和2。鉴定和功能定义酪氨酸激酶在Dsh调控和通路特异性反应中的作用。我们的质谱研究表明,Dsh的不同磷酸化有助于途径选择,我们已经确定了几种作用于Dsh的激酶。磷酸化事件的生理和医学相关性将在体内建立。这将通过生成针对Dsh中相关磷酸化位点的特异性抗血清来补充。这些可能具有诊断潜力。公共卫生相关性:正确Wnt信号通路的调控和选择是发育、组织功能和体内平衡的基本特征。Wnt的失调与许多疾病有关,从纤毛病和血管生成缺陷到癌症(例如,一些通路成分是肿瘤抑制因子或原癌基因)。该应用程序解决了Wnt/ frizzled1信号特异性关键成分dishveled的分子调控;这里获得的信息将对几种医学疾病具有重要意义。
英文摘要
DESCRIPTION (provided by applicant): Frizzled (Fz) receptors act as signal transducers of Wnt growth factors via several effector pathways, notably Wnt/2-catenin (2-cat) and Fz/planar cell polarity (PCP) signaling. Fz/PCP and Wnt-Fz/2-cat signaling diverge downstream of the cytoplasmic factor Dishevelled (Dsh). Often both pathways act in the same tissues, and a tight regulation of signaling specificity is essential for normal development and cellular homeostasis. In deregulated scenarios, selection of the wrong Fz-pathway often leads to disease (i.e. PKD or cancer). Although a molecular framework for both pathways is established, very little is known about the regulation of Wnt/Fz-Dsh signaling specificity. This application investigates the molecular aspects of signaling specificity distinguishing between Wnt-Fz/2-Cat and Fz/PCP signaling. We will address this in Drosophila (the model organism where both pathways were discovered) and in mammalian cell culture. The specific focus is the regulation of Dsh by phosphorylation. Dsh is a cytoplasmic factor shared between both pathways and recruited to the membrane by Fz receptors. Based on preliminary data we hypothesize that Dsh is differentially phosphorylated in a pathway specific manner. A combination of cell culture, in vivo, and biochemical studies will dissect the phosphorylation events on Dsh that switch its function between the Wnt- Fz pathways. The Specific Aims are: 1. To determine specific phosphorylation event(s) on Dsh and their role in the selection of the signaling outcome; and 2. To identify and functionally define Tyrosine kinases acting in Dsh regulation and pathway specific responses. Our mass-spectrometry studies indicated that differential phosphorylation of Dsh contributes to pathway selection and we have identified several kinases acting on Dsh. Physiological and medical relevance of the phosphorylation events will be established in vivo. This will be complemented by the generation of specific antisera to the relevant phosphorylated sites in Dsh. These are likely to have diagnostic potential. PUBLIC HEALTH RELEVANCE: The regulation and selection of the correct Wnt signaling pathways is an essential feature of development and tissue function and homeostasis. Deregulation of Wnt is linked to many diseases, ranging from ciliopathies and angiogenesis defects, to cancer (e.g. several pathway components are tumor suppressors or proto-oncogenes). This application addresses the molecular regulation of Dishvelled a key component in Wnt/Frizzled-signaling specificity; the information acquired here will be of high significance for several medical disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nuclear import of beta-Catenin in Wnt-signaling
-
批准号:9917359
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2020
-
负责人:Marek Mlodzik
-
依托单位:
Nuclear import of beta-Catenin in Wnt-signaling
-
批准号:10094218
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2020
-
负责人:Marek Mlodzik
-
依托单位:
Wnt/Frizzled-PCP signaling in development and disease
-
批准号:9912774
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2018
-
负责人:Marek Mlodzik
-
依托单位:
Wnt/Frizzled-PCP signaling in development and disease
-
批准号:10631665
-
项目类别:
-
资助金额:$66.63万
-
财政年份:2018
-
负责人:Marek Mlodzik
-
依托单位:
Wnt/Frizzled-PCP signaling in development and disease
-
批准号:10397149
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2018
-
负责人:Marek Mlodzik
-
依托单位:
Wnt/Frizzled-PCP signaling in development and disease
-
批准号:10159276
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2018
-
负责人:Marek Mlodzik
-
依托单位:
Wnt/Frizzled-PCP signaling in development and disease
-
批准号:9486438
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2018
-
负责人:Marek Mlodzik
-
依托单位:
Ubiquitin-like protein modifications in planar cell polarity
-
批准号:8628229
-
项目类别:
-
资助金额:$32.21万
-
财政年份:2014
-
负责人:Marek Mlodzik
-
依托单位:
Ubiquitin-like protein modifications in planar cell polarity
-
批准号:9240642
-
项目类别:
-
资助金额:$32.21万
-
财政年份:2014
-
负责人:Marek Mlodzik
-
依托单位:
A Novel Signaling Pathway in Planar Cell Polarity Establishment
-
批准号:8368456
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2012
-
负责人:Marek Mlodzik
-
依托单位:
A Novel Signaling Pathway in Planar Cell Polarity Establishment
-
批准号:8514671
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2012
-
负责人:Marek Mlodzik
-
依托单位:
Planar Cell Polarity regulation by transmembrane proteins
-
批准号:9185637
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2012
-
负责人:Marek Mlodzik
-
依托单位:
PCP-regulated directed cell motility
-
批准号:8535799
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2012
-
负责人:Marek Mlodzik
-
依托单位:
PCP-regulated directed cell motility
-
批准号:8731920
-
项目类别:
-
资助金额:$34.64万
-
财政年份:2012
-
负责人:Marek Mlodzik
-
依托单位:
PCP-regulated directed cell motility
-
批准号:8365295
-
项目类别:
-
资助金额:$34.64万
-
财政年份:2012
-
负责人:Marek Mlodzik
-
依托单位:
Planar Cell Polarity regulation by transmembrane proteins
-
批准号:9330192
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2012
-
负责人:Marek Mlodzik
-
依托单位:
Dsh/Dvl Phosphorylation and Signaling Outcome
-
批准号:7915351
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2009
-
负责人:Marek Mlodzik
-
依托单位:
Cell adhesion and photoreceptor morphogenesis in the retina
-
批准号:7462851
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2003
-
负责人:Marek Mlodzik
-
依托单位:
Ommatidial rotation and cell motility in the eye
-
批准号:7248599
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2003
-
负责人:Marek Mlodzik
-
依托单位:
Ommatidial rotation and cell motility in the eye
-
批准号:6756412
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2003
-
负责人:Marek Mlodzik
-
依托单位:
海外基金